0002-9401Level 3
Kisunla (donanemab-azbt)
**Product type:** Human Prescription Drug
**Active ingredient:** DONANEMAB
**Strength:** 17.5 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intravenous
**Labeler:** Eli Lilly and Company
**Marketing category:** BLA (BLA761248)
GET
/api/v1/systems/ndc_fda/nodes/0002-9401Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.